Sam Chun Dang Pharm Co, Ltd

FDA inspection history in Hwaseong, South Korea, 2019 to 2020

1
Close-out
1
Form 483

Every document, by year

  • Close-out
  • Form 483

2019: one Form 483; 2020: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–20One Form 483 and one close-out letter, at Hwaseong, South Korea.

Cited most

Across all Sam Chun Dang Pharm Co observations on file

The complete Sam Chun Dang Pharm Co file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2020-05-13Close-out Close-out letter$99
2019-10-25483 Form 483$99

Investigators on these documents

Philip F. Istafanos (1)Yvins Dezan (1)

FEI number 3008425092 · most recent document May 13, 2020

About Sam Chun Dang Pharm Co, Ltd

How many FDA Form 483s has Sam Chun Dang Pharm Co, Ltd received?

FDA Intel has 1 Form 483 on file for Sam Chun Dang Pharm Co, Ltd; the most recent is dated Oct 25, 2019.

When was Sam Chun Dang Pharm Co, Ltd last inspected by FDA?

The most recent FDA inspection document on file for Sam Chun Dang Pharm Co, Ltd is a Form 483 dated Oct 25, 2019, for the site in Hwaseong, South Korea.

What did FDA cite at Sam Chun Dang Pharm Co, Ltd?

The regulations cited most in the observations on file for Sam Chun Dang Pharm Co, Ltd are 21 CFR 211.160(b) (General requirements), 3 times; 21 CFR 211.42(c)(10) (Design and construction features), 3 times; 21 CFR 211.68(b) (Automatic, mechanical, and electronic equipment), 2 times.